From: Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
Variable | 10-Year signature | Early signature | Late signature |
---|---|---|---|
ALDH1A1 |  |  | −0.194 |
ANP32E | 0.143 | 0.010 | 0.083 |
CRABP2 | 0.084 | 0.207 | Â |
CXCL12 |  | −0.183 |  |
CXCR4 | 0.142 | Â | 0.056 |
EGFR |  |  | −0.030 |
ELF5 | −0.046 | −0.001 |  |
FGF2 | −0.178 |  | −0.232 |
IGF1 | −0.029 | −0.017 |  |
IGJ | −0.086 | −0.037 | −0.030 |
IL6ST |  | −0.044 |  |
LINC00341 | − 0.463 | − 0.362 | − 0.392 |
LRRC48 |  | − 0.104 |  |
MMP9 | 0.043 | Â | 0.064 |
MPZL1 | 0.276 | 0.066 | 0.043 |
NUSAP1 | 0.088 | 0.065 | Â |
PBX1 | 0.159 | Â | 0.375 |
PDZK1 | −0.011 |  | −0.063 |
PGR |  | − 0.073 |  |
PRC1 | Â | 0.019 | Â |
RGL1 | −0.429 | − 0.166 | − 0.161 |
RRM2 | 0.077 | 0.124 | Â |
SFRP1 | −0.017 |  | −0.278 |
STC2 | −0.087 | −0.068 |  |
TNF | −0.029 |  | −0.026 |
ZEB2 |  |  | −0.138 |
CTS | 0.514 | 0.409 | 0.516 |